Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 7.22917853 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.22917853 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.92315656 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.92315656 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.56464374 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.39795786 |
7 | tryptophan catabolic process (GO:0006569) | 5.97163606 |
8 | indole-containing compound catabolic process (GO:0042436) | 5.97163606 |
9 | indolalkylamine catabolic process (GO:0046218) | 5.97163606 |
10 | kynurenine metabolic process (GO:0070189) | 5.86875808 |
11 | bile acid biosynthetic process (GO:0006699) | 5.75360041 |
12 | alpha-linolenic acid metabolic process (GO:0036109) | 5.74196929 |
13 | tryptophan metabolic process (GO:0006568) | 5.62479399 |
14 | urea metabolic process (GO:0019627) | 5.60015749 |
15 | urea cycle (GO:0000050) | 5.60015749 |
16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.53342738 |
17 | glyoxylate metabolic process (GO:0046487) | 5.49266934 |
18 | negative regulation of fibrinolysis (GO:0051918) | 5.45904189 |
19 | protein carboxylation (GO:0018214) | 5.33150632 |
20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.33150632 |
21 | regulation of fibrinolysis (GO:0051917) | 5.21044233 |
22 | cysteine metabolic process (GO:0006534) | 5.17189545 |
23 | hemidesmosome assembly (GO:0031581) | 5.15381134 |
24 | nitrogen cycle metabolic process (GO:0071941) | 5.12340357 |
25 | complement activation, alternative pathway (GO:0006957) | 5.11273444 |
26 | sulfur amino acid catabolic process (GO:0000098) | 5.07814065 |
27 | regulation of protein activation cascade (GO:2000257) | 5.06414158 |
28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.02207563 |
29 | bile acid metabolic process (GO:0008206) | 4.97813423 |
30 | regulation of cholesterol esterification (GO:0010872) | 4.93126743 |
31 | serine family amino acid catabolic process (GO:0009071) | 4.90603868 |
32 | regulation of triglyceride catabolic process (GO:0010896) | 4.87062425 |
33 | reverse cholesterol transport (GO:0043691) | 4.83762521 |
34 | plasma lipoprotein particle remodeling (GO:0034369) | 4.75317854 |
35 | protein-lipid complex remodeling (GO:0034368) | 4.75317854 |
36 | macromolecular complex remodeling (GO:0034367) | 4.75317854 |
37 | aromatic amino acid family metabolic process (GO:0009072) | 4.74169069 |
38 | phospholipid efflux (GO:0033700) | 4.73429998 |
39 | regulation of complement activation (GO:0030449) | 4.72605099 |
40 | negative regulation of sterol transport (GO:0032372) | 4.72372741 |
41 | negative regulation of cholesterol transport (GO:0032375) | 4.72372741 |
42 | homocysteine metabolic process (GO:0050667) | 4.63507197 |
43 | tyrosine metabolic process (GO:0006570) | 4.55809281 |
44 | lysine catabolic process (GO:0006554) | 4.52880589 |
45 | lysine metabolic process (GO:0006553) | 4.52880589 |
46 | triglyceride homeostasis (GO:0070328) | 4.52624650 |
47 | acylglycerol homeostasis (GO:0055090) | 4.52624650 |
48 | amino-acid betaine metabolic process (GO:0006577) | 4.50707571 |
49 | plasma lipoprotein particle clearance (GO:0034381) | 4.46859820 |
50 | alpha-amino acid catabolic process (GO:1901606) | 4.42905274 |
51 | bile acid and bile salt transport (GO:0015721) | 4.37048914 |
52 | regulation of hypersensitivity (GO:0002883) | 4.34021488 |
53 | cholesterol efflux (GO:0033344) | 4.30970841 |
54 | cellular ketone body metabolic process (GO:0046950) | 4.28939191 |
55 | response to peptidoglycan (GO:0032494) | 4.27810747 |
56 | cellular glucuronidation (GO:0052695) | 4.24151480 |
57 | neutrophil activation involved in immune response (GO:0002283) | 4.23741197 |
58 | glycine metabolic process (GO:0006544) | 4.22989844 |
59 | indolalkylamine metabolic process (GO:0006586) | 4.19878380 |
60 | plasma lipoprotein particle assembly (GO:0034377) | 4.16353897 |
61 | imidazole-containing compound metabolic process (GO:0052803) | 4.15683808 |
62 | drug catabolic process (GO:0042737) | 4.15377386 |
63 | amine catabolic process (GO:0009310) | 4.09847116 |
64 | cellular biogenic amine catabolic process (GO:0042402) | 4.09847116 |
65 | cellular amino acid catabolic process (GO:0009063) | 4.06571341 |
66 | glutamate metabolic process (GO:0006536) | 4.05584641 |
67 | ethanol oxidation (GO:0006069) | 4.03848549 |
68 | coenzyme catabolic process (GO:0009109) | 4.03468619 |
69 | benzene-containing compound metabolic process (GO:0042537) | 4.02605290 |
70 | serine family amino acid metabolic process (GO:0009069) | 4.00313929 |
71 | cellular modified amino acid catabolic process (GO:0042219) | 3.93647320 |
72 | low-density lipoprotein particle remodeling (GO:0034374) | 3.93364693 |
73 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.91388472 |
74 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.91121457 |
75 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.91121457 |
76 | fibrinolysis (GO:0042730) | 3.90336212 |
77 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.85850120 |
78 | serine family amino acid biosynthetic process (GO:0009070) | 3.84411895 |
79 | arginine metabolic process (GO:0006525) | 3.83703489 |
80 | positive regulation of lipid catabolic process (GO:0050996) | 3.82688813 |
81 | phospholipid homeostasis (GO:0055091) | 3.82598005 |
82 | aldehyde catabolic process (GO:0046185) | 3.80333093 |
83 | cholesterol homeostasis (GO:0042632) | 3.78818130 |
84 | protein-lipid complex assembly (GO:0065005) | 3.78290435 |
85 | glucuronate metabolic process (GO:0019585) | 3.76398013 |
86 | uronic acid metabolic process (GO:0006063) | 3.76398013 |
87 | intestinal cholesterol absorption (GO:0030299) | 3.73361633 |
88 | sterol homeostasis (GO:0055092) | 3.73206011 |
89 | regulation of cholesterol homeostasis (GO:2000188) | 3.72875534 |
90 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.72801316 |
91 | detection of molecule of bacterial origin (GO:0032490) | 3.70206282 |
92 | ketone body metabolic process (GO:1902224) | 3.70163830 |
93 | negative regulation of lipase activity (GO:0060192) | 3.68990261 |
94 | plasma lipoprotein particle organization (GO:0071827) | 3.68311892 |
95 | oligosaccharide catabolic process (GO:0009313) | 3.67283408 |
96 | regulation of bile acid biosynthetic process (GO:0070857) | 3.67137826 |
97 | blood coagulation, intrinsic pathway (GO:0007597) | 3.64093104 |
98 | complement activation, classical pathway (GO:0006958) | 3.63851487 |
99 | pinocytosis (GO:0006907) | 3.62657188 |
100 | flavonoid metabolic process (GO:0009812) | 3.61843760 |
101 | complement activation (GO:0006956) | 3.61124624 |
102 | glycosphingolipid catabolic process (GO:0046479) | 3.60683627 |
103 | organic acid catabolic process (GO:0016054) | 3.59274131 |
104 | carboxylic acid catabolic process (GO:0046395) | 3.59274131 |
105 | cofactor catabolic process (GO:0051187) | 3.59174173 |
106 | short-chain fatty acid metabolic process (GO:0046459) | 3.58870019 |
107 | protein activation cascade (GO:0072376) | 3.58304159 |
108 | lipoprotein metabolic process (GO:0042157) | 3.56353145 |
109 | acetyl-CoA metabolic process (GO:0006084) | 3.54702717 |
110 | immunoglobulin mediated immune response (GO:0016064) | 3.49491255 |
111 | detection of other organism (GO:0098543) | 3.41111304 |
112 | detection of external biotic stimulus (GO:0098581) | 3.33509838 |
113 | negative regulation of interleukin-12 production (GO:0032695) | 3.33190405 |
114 | macrophage activation involved in immune response (GO:0002281) | 3.22483107 |
115 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.22425413 |
116 | glycolipid catabolic process (GO:0019377) | 3.21082115 |
117 | detection of bacterium (GO:0016045) | 3.19219952 |
118 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.15128712 |
119 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.15128712 |
120 | modulation by symbiont of host immune response (GO:0052553) | 3.15128712 |
121 | positive regulation by symbiont of host defense response (GO:0052509) | 3.15128712 |
122 | modulation by symbiont of host defense response (GO:0052031) | 3.15128712 |
123 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.15128712 |
124 | regulation of macrophage chemotaxis (GO:0010758) | 3.09921432 |
125 | cellular extravasation (GO:0045123) | 3.07829850 |
126 | regulation of mast cell degranulation (GO:0043304) | 3.06655861 |
127 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.02783747 |
128 | ceramide catabolic process (GO:0046514) | 3.01161196 |
129 | regulation of apoptotic cell clearance (GO:2000425) | 2.99221636 |
130 | detection of biotic stimulus (GO:0009595) | 2.95782902 |
131 | positive regulation of mast cell degranulation (GO:0043306) | 2.92900932 |
132 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.92900932 |
133 | positive regulation of hemostasis (GO:1900048) | 2.91299242 |
134 | positive regulation of blood coagulation (GO:0030194) | 2.91299242 |
135 | negative regulation of protein activation cascade (GO:2000258) | 2.90351668 |
136 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.89385719 |
137 | positive regulation of leukocyte degranulation (GO:0043302) | 2.88868063 |
138 | response to muramyl dipeptide (GO:0032495) | 2.88232006 |
139 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.86770313 |
140 | positive regulation of mast cell activation (GO:0033005) | 2.85799407 |
141 | positive regulation of phagocytosis (GO:0050766) | 2.84998948 |
142 | positive regulation of coagulation (GO:0050820) | 2.83044574 |
143 | regulation of leukocyte degranulation (GO:0043300) | 2.82137452 |
144 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.81382538 |
145 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.80786991 |
146 | positive regulation of chemokine secretion (GO:0090197) | 2.79124508 |
147 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.77571301 |
148 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.75058533 |
149 | protein-lipid complex subunit organization (GO:0071825) | 2.75020257 |
150 | negative regulation of complement activation (GO:0045916) | 2.71008594 |
151 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.70783271 |
152 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.69811128 |
153 | acute-phase response (GO:0006953) | 2.69607174 |
154 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.64764629 |
155 | regulation of cholesterol storage (GO:0010885) | 2.62479125 |
156 | response to thyroid hormone (GO:0097066) | 2.62396818 |
157 | granulocyte activation (GO:0036230) | 2.61403469 |
158 | regulation of mast cell activation (GO:0033003) | 2.59103520 |
159 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.58924003 |
160 | regulation of chemokine secretion (GO:0090196) | 2.58828572 |
161 | B cell mediated immunity (GO:0019724) | 2.58290717 |
162 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.57664965 |
163 | regulation of phagocytosis (GO:0050764) | 2.54368533 |
164 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.52617224 |
165 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.52517666 |
166 | myeloid cell activation involved in immune response (GO:0002275) | 2.51647087 |
167 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.51634006 |
168 | regulation of superoxide anion generation (GO:0032928) | 2.51446807 |
169 | low-density lipoprotein particle clearance (GO:0034383) | 2.51442043 |
170 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.51379402 |
171 | positive regulation of type 2 immune response (GO:0002830) | 2.51320557 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.15025166 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.05342567 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.77171716 |
4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.54510839 |
5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.36914705 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.97069365 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.89849290 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.73472523 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.96199045 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.86998928 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.59981690 |
12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.34310981 |
13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.11282030 |
14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05960974 |
15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.04246562 |
16 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.00792143 |
17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4765780 |
18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99136965 |
19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.93499740 |
20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.89463279 |
21 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86175788 |
22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.84312041 |
23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.78478072 |
24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.73804873 |
25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.69826586 |
26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67208570 |
27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.64383872 |
28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.63891008 |
29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63682721 |
30 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59929283 |
31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59249443 |
32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57422803 |
33 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54767136 |
34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.54595116 |
35 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.52087679 |
36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49396124 |
37 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40975941 |
38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38278053 |
39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.34367418 |
40 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33600810 |
41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32858666 |
42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30815250 |
43 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30609943 |
44 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.29573069 |
45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27946531 |
46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27394363 |
47 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.21911318 |
48 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.21911318 |
49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.20487878 |
50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.19362702 |
51 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13821365 |
52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13261651 |
53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10993165 |
54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10334596 |
55 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09817627 |
56 | MAF_26560356_Chip-Seq_TH1_Human | 1.08124888 |
57 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07772821 |
58 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05429519 |
59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04821779 |
60 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04578907 |
61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04292171 |
62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04164229 |
63 | MYB_26560356_Chip-Seq_TH2_Human | 1.01751513 |
64 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01523794 |
65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00074490 |
66 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99321770 |
67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98336689 |
68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98098476 |
69 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98096370 |
70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97276573 |
71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97025746 |
72 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96891882 |
73 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96720261 |
74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96593362 |
75 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95683495 |
76 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95676119 |
77 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95539688 |
78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94582208 |
79 | MYB_26560356_Chip-Seq_TH1_Human | 0.94465005 |
80 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93003747 |
81 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92062265 |
82 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91000076 |
83 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90635836 |
84 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89361723 |
85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87294530 |
86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86539138 |
87 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85796379 |
88 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.85530794 |
89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78720863 |
90 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.78311602 |
91 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.77954030 |
92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77804459 |
93 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76157941 |
94 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.73994925 |
95 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.73613122 |
96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73586602 |
97 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72595002 |
98 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72135956 |
99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70420398 |
100 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69593792 |
101 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69005373 |
102 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.68230040 |
103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.67576739 |
104 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67458789 |
105 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.65562604 |
106 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.64254977 |
107 | GATA2_19941826_ChIP-Seq_K562_Human | 0.63195669 |
108 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.62851162 |
109 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61131389 |
110 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60871301 |
111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60446042 |
112 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.60445981 |
113 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59958233 |
114 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.59946307 |
115 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.59626149 |
116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.58296225 |
117 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58052307 |
118 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.57639190 |
119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.57409336 |
120 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57400425 |
121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.55637037 |
122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.55637037 |
123 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53841430 |
124 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.53819959 |
125 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53033464 |
126 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52395620 |
127 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.52243776 |
128 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.52175202 |
129 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.50686965 |
130 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.50361660 |
131 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.49800542 |
132 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.49665668 |
133 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.48148267 |
134 | AR_20517297_ChIP-Seq_VCAP_Human | 0.47959908 |
135 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.47753726 |
136 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.46757275 |
137 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.45824032 |
138 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.44952462 |
139 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44791861 |
140 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.44503444 |
141 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.44176803 |
142 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.44143872 |
143 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43904761 |
144 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43565077 |
145 | CBP_21632823_ChIP-Seq_H3396_Human | 0.43431173 |
146 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42904689 |
147 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.42609393 |
148 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.42567937 |
149 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.42292882 |
150 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.42064008 |
151 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.41022025 |
152 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.40021419 |
153 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.39804856 |
154 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.39300094 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.12538021 |
2 | * MP0005360_urolithiasis | 7.08859510 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.23232421 |
4 | MP0005365_abnormal_bile_salt | 5.95608921 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.05221898 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.95224028 |
7 | MP0003252_abnormal_bile_duct | 3.87168318 |
8 | MP0010329_abnormal_lipoprotein_level | 3.55488650 |
9 | MP0009840_abnormal_foam_cell | 3.44217107 |
10 | MP0005083_abnormal_biliary_tract | 2.97023512 |
11 | MP0003172_abnormal_lysosome_physiology | 2.80323679 |
12 | MP0003195_calcinosis | 2.78386351 |
13 | MP0001666_abnormal_nutrient_absorption | 2.71902320 |
14 | MP0001835_abnormal_antigen_presentation | 2.69077206 |
15 | * MP0005332_abnormal_amino_acid | 2.58708260 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.39153895 |
17 | MP0002148_abnormal_hypersensitivity_rea | 2.34647958 |
18 | MP0000609_abnormal_liver_physiology | 2.21554849 |
19 | MP0004019_abnormal_vitamin_homeostasis | 2.16865731 |
20 | MP0002118_abnormal_lipid_homeostasis | 2.07596832 |
21 | MP0005000_abnormal_immune_tolerance | 1.97123841 |
22 | MP0005387_immune_system_phenotype | 1.93398470 |
23 | MP0001790_abnormal_immune_system | 1.93398470 |
24 | MP0002138_abnormal_hepatobiliary_system | 1.92183854 |
25 | MP0006054_spinal_hemorrhage | 1.86412910 |
26 | MP0005319_abnormal_enzyme/_coenzyme | 1.83488861 |
27 | MP0003183_abnormal_peptide_metabolism | 1.82188535 |
28 | MP0000579_abnormal_nail_morphology | 1.80925793 |
29 | MP0003868_abnormal_feces_composition | 1.77654045 |
30 | MP0002452_abnormal_antigen_presenting | 1.72451325 |
31 | MP0008260_abnormal_autophagy | 1.72161314 |
32 | MP0001800_abnormal_humoral_immune | 1.69408011 |
33 | MP0001764_abnormal_homeostasis | 1.65730717 |
34 | MP0002723_abnormal_immune_serum | 1.63706942 |
35 | MP0009278_abnormal_bone_marrow | 1.63566442 |
36 | MP0005397_hematopoietic_system_phenotyp | 1.59050628 |
37 | MP0001545_abnormal_hematopoietic_system | 1.59050628 |
38 | MP0005671_abnormal_response_to | 1.56030645 |
39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55905223 |
40 | MP0000858_altered_metastatic_potential | 1.51855283 |
41 | MP0009697_abnormal_copulation | 1.46594017 |
42 | MP0005451_abnormal_body_composition | 1.42421665 |
43 | MP0002420_abnormal_adaptive_immunity | 1.39393654 |
44 | MP0001819_abnormal_immune_cell | 1.39301273 |
45 | MP0005164_abnormal_response_to | 1.35635441 |
46 | MP0010155_abnormal_intestine_physiology | 1.35354384 |
47 | MP0003705_abnormal_hypodermis_morpholog | 1.34823272 |
48 | MP0003656_abnormal_erythrocyte_physiolo | 1.34502794 |
49 | MP0002998_abnormal_bone_remodeling | 1.33630038 |
50 | MP0004381_abnormal_hair_follicle | 1.32843513 |
51 | MP0002132_abnormal_respiratory_system | 1.30504843 |
52 | MP0009333_abnormal_splenocyte_physiolog | 1.29537825 |
53 | MP0003566_abnormal_cell_adhesion | 1.28322341 |
54 | * MP0009643_abnormal_urine_homeostasis | 1.27740832 |
55 | MP0003011_delayed_dark_adaptation | 1.26777337 |
56 | MP0001849_ear_inflammation | 1.23096854 |
57 | MP0000598_abnormal_liver_morphology | 1.22191360 |
58 | MP0000343_altered_response_to | 1.20720020 |
59 | MP0003828_pulmonary_edema | 1.18476375 |
60 | MP0002405_respiratory_system_inflammati | 1.18317422 |
61 | MP0008004_abnormal_stomach_pH | 1.15224774 |
62 | MP0003186_abnormal_redox_activity | 1.15081910 |
63 | MP0000604_amyloidosis | 1.14426037 |
64 | MP0009764_decreased_sensitivity_to | 1.14092949 |
65 | MP0001851_eye_inflammation | 1.13433391 |
66 | MP0001216_abnormal_epidermal_layer | 1.13061997 |
67 | MP0009763_increased_sensitivity_to | 1.09560136 |
68 | MP0002254_reproductive_system_inflammat | 1.08648340 |
69 | MP0008469_abnormal_protein_level | 1.05271920 |
70 | MP0005647_abnormal_sex_gland | 1.01944551 |
71 | MP0005167_abnormal_blood-brain_barrier | 1.01525108 |
72 | MP0000716_abnormal_immune_system | 0.98165317 |
73 | MP0005409_darkened_coat_color | 0.94834423 |
74 | MP0003448_altered_tumor_morphology | 0.91869837 |
75 | MP0005310_abnormal_salivary_gland | 0.91427676 |
76 | MP0003950_abnormal_plasma_membrane | 0.91324769 |
77 | * MP0009642_abnormal_blood_homeostasis | 0.89222118 |
78 | MP0001915_intracranial_hemorrhage | 0.88150725 |
79 | MP0002060_abnormal_skin_morphology | 0.87878664 |
80 | MP0005408_hypopigmentation | 0.87126782 |
81 | * MP0005636_abnormal_mineral_homeostasis | 0.86744817 |
82 | MP0010368_abnormal_lymphatic_system | 0.85812173 |
83 | MP0005464_abnormal_platelet_physiology | 0.85619945 |
84 | MP0003436_decreased_susceptibility_to | 0.83809380 |
85 | MP0009765_abnormal_xenobiotic_induced | 0.80398646 |
86 | MP0000920_abnormal_myelination | 0.79773232 |
87 | MP0000465_gastrointestinal_hemorrhage | 0.78242738 |
88 | MP0005376_homeostasis/metabolism_phenot | 0.76429077 |
89 | MP0002078_abnormal_glucose_homeostasis | 0.75574994 |
90 | MP0002398_abnormal_bone_marrow | 0.75417728 |
91 | MP0002429_abnormal_blood_cell | 0.75204728 |
92 | MP0005084_abnormal_gallbladder_morpholo | 0.74228584 |
93 | MP0005670_abnormal_white_adipose | 0.74039372 |
94 | MP0002971_abnormal_brown_adipose | 0.73724156 |
95 | MP0004130_abnormal_muscle_cell | 0.73085342 |
96 | MP0006036_abnormal_mitochondrial_physio | 0.70678338 |
97 | MP0000467_abnormal_esophagus_morphology | 0.70625074 |
98 | MP0005334_abnormal_fat_pad | 0.70208357 |
99 | MP0000689_abnormal_spleen_morphology | 0.70172706 |
100 | MP0002796_impaired_skin_barrier | 0.70016717 |
101 | MP0003300_gastrointestinal_ulcer | 0.69958672 |
102 | MP0003091_abnormal_cell_migration | 0.69872630 |
103 | MP0010678_abnormal_skin_adnexa | 0.69300804 |
104 | MP0005220_abnormal_exocrine_pancreas | 0.68431064 |
105 | MP0000678_abnormal_parathyroid_gland | 0.68101698 |
106 | MP0003690_abnormal_glial_cell | 0.66187969 |
107 | MP0006082_CNS_inflammation | 0.64126394 |
108 | MP0001881_abnormal_mammary_gland | 0.63233638 |
109 | MP0009053_abnormal_anal_canal | 0.62303693 |
110 | MP0002876_abnormal_thyroid_physiology | 0.61347968 |
111 | MP0005058_abnormal_lysosome_morphology | 0.61098189 |
112 | MP0003724_increased_susceptibility_to | 0.60215445 |
113 | MP0001661_extended_life_span | 0.57610701 |
114 | MP0005266_abnormal_metabolism | 0.57360254 |
115 | MP0005535_abnormal_body_temperature | 0.56818532 |
116 | * MP0002136_abnormal_kidney_physiology | 0.56793000 |
117 | MP0000639_abnormal_adrenal_gland | 0.56240823 |
118 | MP0005448_abnormal_energy_balance | 0.55585929 |
119 | MP0002928_abnormal_bile_duct | 0.51139193 |
120 | MP0008873_increased_physiological_sensi | 0.50719001 |
121 | MP0005395_other_phenotype | 0.50531262 |
122 | * MP0001845_abnormal_inflammatory_respons | 0.50335490 |
123 | * MP0001756_abnormal_urination | 0.49741414 |
124 | MP0003329_amyloid_beta_deposits | 0.49622101 |
125 | MP0003075_altered_response_to | 0.49372086 |
126 | MP0001853_heart_inflammation | 0.49317536 |
127 | MP0005166_decreased_susceptibility_to | 0.48901402 |
128 | MP0004782_abnormal_surfactant_physiolog | 0.46787650 |
129 | MP0003638_abnormal_response/metabolism_ | 0.46594408 |
130 | MP0008874_decreased_physiological_sensi | 0.45533400 |
131 | MP0004947_skin_inflammation | 0.45349707 |
132 | MP0003718_maternal_effect | 0.44681847 |
133 | MP0003303_peritoneal_inflammation | 0.43036941 |
134 | MP0000249_abnormal_blood_vessel | 0.41916241 |
135 | MP0006035_abnormal_mitochondrial_morpho | 0.41703958 |
136 | MP0002419_abnormal_innate_immunity | 0.41565620 |
137 | MP0009115_abnormal_fat_cell | 0.40943002 |
138 | MP0005666_abnormal_adipose_tissue | 0.39695339 |
139 | MP0005025_abnormal_response_to | 0.38910807 |
140 | MP0000685_abnormal_immune_system | 0.38117242 |
141 | MP0002168_other_aberrant_phenotype | 0.36835018 |
142 | MP0010234_abnormal_vibrissa_follicle | 0.36448811 |
143 | MP0001243_abnormal_dermal_layer | 0.36409031 |
144 | MP0009785_altered_susceptibility_to | 0.36390061 |
145 | MP0003953_abnormal_hormone_level | 0.36020392 |
146 | MP0004264_abnormal_extraembryonic_tissu | 0.34689105 |
147 | MP0005023_abnormal_wound_healing | 0.34201600 |
148 | MP0002970_abnormal_white_adipose | 0.34138934 |
149 | MP0003453_abnormal_keratinocyte_physiol | 0.34067211 |
150 | MP0009384_cardiac_valve_regurgitation | 0.33054059 |
151 | MP0004883_abnormal_blood_vessel | 0.32846027 |
152 | MP0001533_abnormal_skeleton_physiology | 0.31110375 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.29307085 |
2 | Intrahepatic cholestasis (HP:0001406) | 7.09595457 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.03278415 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.46054842 |
5 | Hypobetalipoproteinemia (HP:0003563) | 6.36645825 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 6.25936726 |
7 | Xanthomatosis (HP:0000991) | 6.18214143 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.29638697 |
9 | Complement deficiency (HP:0004431) | 5.19427073 |
10 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.92328904 |
11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.92328904 |
12 | Abnormality of glycolipid metabolism (HP:0010969) | 4.92328904 |
13 | Joint hemorrhage (HP:0005261) | 4.78921184 |
14 | Hypolipoproteinemia (HP:0010981) | 4.71072320 |
15 | Hyperammonemia (HP:0001987) | 4.43855447 |
16 | Epidermoid cyst (HP:0200040) | 4.36873075 |
17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.34653502 |
18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.33226670 |
19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.31601780 |
20 | Fat malabsorption (HP:0002630) | 4.19247039 |
21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.16727692 |
22 | Hyperglycinemia (HP:0002154) | 4.14328426 |
23 | Ketosis (HP:0001946) | 4.12691557 |
24 | Hypoalphalipoproteinemia (HP:0003233) | 4.02640071 |
25 | Abnormality of methionine metabolism (HP:0010901) | 4.00671891 |
26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.98861596 |
27 | Recurrent bacterial skin infections (HP:0005406) | 3.93024134 |
28 | Hyperglycinuria (HP:0003108) | 3.88567019 |
29 | Milia (HP:0001056) | 3.87634223 |
30 | Abnormality of complement system (HP:0005339) | 3.84271393 |
31 | Abnormality of glycine metabolism (HP:0010895) | 3.80633915 |
32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.80633915 |
33 | Abnormality of macrophages (HP:0004311) | 3.78083327 |
34 | Hypercholesterolemia (HP:0003124) | 3.77486677 |
35 | Increased cerebral lipofuscin (HP:0011813) | 3.75072706 |
36 | Hypoglycemic coma (HP:0001325) | 3.74651220 |
37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.74411687 |
38 | Recurrent abscess formation (HP:0002722) | 3.74214734 |
39 | Conjugated hyperbilirubinemia (HP:0002908) | 3.73719573 |
40 | Thick nail (HP:0001805) | 3.71669788 |
41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.66499647 |
42 | Vacuolated lymphocytes (HP:0001922) | 3.65432721 |
43 | Orchitis (HP:0100796) | 3.53007051 |
44 | Myositis (HP:0100614) | 3.52845528 |
45 | Dysostosis multiplex (HP:0000943) | 3.39106146 |
46 | Onycholysis (HP:0001806) | 3.36120639 |
47 | Purpura (HP:0000979) | 3.34921497 |
48 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32335174 |
49 | Hyperbilirubinemia (HP:0002904) | 3.29652193 |
50 | Plantar hyperkeratosis (HP:0007556) | 3.28618466 |
51 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.25942638 |
52 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.25513730 |
53 | Retrobulbar optic neuritis (HP:0100654) | 3.24242556 |
54 | Optic neuritis (HP:0100653) | 3.24242556 |
55 | Myocardial infarction (HP:0001658) | 3.20277045 |
56 | Steatorrhea (HP:0002570) | 3.08833898 |
57 | Loss of speech (HP:0002371) | 3.07497341 |
58 | Fragile nails (HP:0001808) | 3.01583742 |
59 | Systemic lupus erythematosus (HP:0002725) | 3.00634629 |
60 | Eczematoid dermatitis (HP:0000976) | 2.98732690 |
61 | Ketoacidosis (HP:0001993) | 2.94856311 |
62 | * Abnormality of nucleobase metabolism (HP:0010932) | 2.90999205 |
63 | Hepatocellular carcinoma (HP:0001402) | 2.90261235 |
64 | Delayed CNS myelination (HP:0002188) | 2.89282066 |
65 | Abnormality of serum amino acid levels (HP:0003112) | 2.81149710 |
66 | Abnormality of nail color (HP:0100643) | 2.78859368 |
67 | Acanthocytosis (HP:0001927) | 2.77468749 |
68 | Hypochromic microcytic anemia (HP:0004840) | 2.73513960 |
69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.72885574 |
70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.72885574 |
71 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.72885574 |
72 | Atrophic scars (HP:0001075) | 2.71925927 |
73 | Spontaneous abortion (HP:0005268) | 2.70998215 |
74 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.69971862 |
75 | Mucopolysacchariduria (HP:0008155) | 2.69971862 |
76 | Skin nodule (HP:0200036) | 2.69362096 |
77 | Vascular calcification (HP:0004934) | 2.69066451 |
78 | Metabolic acidosis (HP:0001942) | 2.67174717 |
79 | Glomerulonephritis (HP:0000099) | 2.64654216 |
80 | Keratoconjunctivitis sicca (HP:0001097) | 2.63826036 |
81 | Epistaxis (HP:0000421) | 2.61202662 |
82 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.61054166 |
83 | Mitral stenosis (HP:0001718) | 2.56951902 |
84 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.56801784 |
85 | Recurrent skin infections (HP:0001581) | 2.56239368 |
86 | Mediastinal lymphadenopathy (HP:0100721) | 2.55094092 |
87 | Obstructive lung disease (HP:0006536) | 2.51311686 |
88 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51311686 |
89 | Increased serum ferritin (HP:0003281) | 2.49985587 |
90 | Alopecia of scalp (HP:0002293) | 2.49800111 |
91 | * Abnormality of purine metabolism (HP:0004352) | 2.47306953 |
92 | Gingivitis (HP:0000230) | 2.46909811 |
93 | Pustule (HP:0200039) | 2.46606655 |
94 | Abnormal blistering of the skin (HP:0008066) | 2.44706855 |
95 | Neurofibrillary tangles (HP:0002185) | 2.43598139 |
96 | Spastic diplegia (HP:0001264) | 2.41907164 |
97 | Gingival bleeding (HP:0000225) | 2.41558598 |
98 | Dicarboxylic aciduria (HP:0003215) | 2.41518180 |
99 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.41518180 |
100 | Cardiovascular calcification (HP:0011915) | 2.39299347 |
101 | Malnutrition (HP:0004395) | 2.38687154 |
102 | Hypoglycemic seizures (HP:0002173) | 2.38007715 |
103 | Abnormal gallbladder morphology (HP:0012437) | 2.37447381 |
104 | Amyloidosis (HP:0011034) | 2.36475956 |
105 | Keratoconjunctivitis (HP:0001096) | 2.35527753 |
106 | Lethargy (HP:0001254) | 2.35300836 |
107 | Gangrene (HP:0100758) | 2.34099223 |
108 | Disinhibition (HP:0000734) | 2.33180568 |
109 | Esophageal varix (HP:0002040) | 2.32537804 |
110 | Cholelithiasis (HP:0001081) | 2.32470457 |
111 | Gout (HP:0001997) | 2.32348539 |
112 | Menorrhagia (HP:0000132) | 2.31659070 |
113 | Irritability (HP:0000737) | 2.28669436 |
114 | Prolonged bleeding time (HP:0003010) | 2.25631643 |
115 | Palmoplantar hyperkeratosis (HP:0000972) | 2.23382415 |
116 | Stomatitis (HP:0010280) | 2.22892648 |
117 | Sensorimotor neuropathy (HP:0007141) | 2.22609972 |
118 | Cholecystitis (HP:0001082) | 2.22192763 |
119 | Abnormal gallbladder physiology (HP:0012438) | 2.22192763 |
120 | Neonatal onset (HP:0003623) | 2.20288474 |
121 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.20116478 |
122 | Hydroxyprolinuria (HP:0003080) | 2.18398825 |
123 | Abnormality of proline metabolism (HP:0010907) | 2.18398825 |
124 | Poikilocytosis (HP:0004447) | 2.17088628 |
125 | Cheilitis (HP:0100825) | 2.16171754 |
126 | Pulmonary infiltrates (HP:0002113) | 2.15605631 |
127 | Ridged nail (HP:0001807) | 2.15254182 |
128 | Pancreatitis (HP:0001733) | 2.14881725 |
129 | Meningitis (HP:0001287) | 2.14466671 |
130 | Nail dystrophy (HP:0008404) | 2.13310918 |
131 | Thrombophlebitis (HP:0004418) | 2.12201830 |
132 | Recurrent fungal infections (HP:0002841) | 2.11482191 |
133 | Late onset (HP:0003584) | 2.08083640 |
134 | Hemorrhage of the eye (HP:0011885) | 2.08060875 |
135 | Abnormality of iron homeostasis (HP:0011031) | 2.05262245 |
136 | Xerostomia (HP:0000217) | 2.03795345 |
137 | Cerebral edema (HP:0002181) | 2.03282203 |
138 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02672104 |
139 | Urticaria (HP:0001025) | 2.02077481 |
140 | Palmar hyperkeratosis (HP:0010765) | 2.01858328 |
141 | Autoimmune thrombocytopenia (HP:0001973) | 2.01023019 |
142 | Arterial thrombosis (HP:0004420) | 2.00974316 |
143 | Generalized aminoaciduria (HP:0002909) | 1.99479880 |
144 | Nephritis (HP:0000123) | 1.99245179 |
145 | Vasculitis (HP:0002633) | 1.97691997 |
146 | Polygenic inheritance (HP:0010982) | 1.96827412 |
147 | Hemoptysis (HP:0002105) | 1.96663370 |
148 | Opisthotonus (HP:0002179) | 1.96450088 |
149 | Brushfield spots (HP:0001088) | 1.95149215 |
150 | Periodontitis (HP:0000704) | 1.95042300 |
151 | Abnormality of the gallbladder (HP:0005264) | 1.93273840 |
152 | Vomiting (HP:0002013) | 1.92860199 |
153 | Rickets (HP:0002748) | 1.89354715 |
154 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89031047 |
155 | Enlarged kidneys (HP:0000105) | 1.88495274 |
156 | Gastrointestinal infarctions (HP:0005244) | 1.87882163 |
157 | Increased mean platelet volume (HP:0011877) | 1.87373707 |
158 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.85572238 |
159 | Pulmonary embolism (HP:0002204) | 1.84768555 |
160 | Peritonitis (HP:0002586) | 1.84051736 |
161 | Abnormal cartilage morphology (HP:0002763) | 1.82454297 |
162 | Renal cortical cysts (HP:0000803) | 1.81840931 |
163 | Reticulocytosis (HP:0001923) | 1.81097334 |
164 | Elevated hepatic transaminases (HP:0002910) | 1.80741076 |
165 | Skin ulcer (HP:0200042) | 1.80501679 |
166 | Joint swelling (HP:0001386) | 1.80349047 |
167 | Metaphyseal irregularity (HP:0003025) | 1.80195927 |
168 | Axonal loss (HP:0003447) | 1.78258024 |
169 | Alkalosis (HP:0001948) | 1.77633220 |
170 | Hypophosphatemic rickets (HP:0004912) | 1.75840179 |
171 | Thrombocytosis (HP:0001894) | 1.74394272 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.76438152 |
2 | SIK1 | 4.59700681 |
3 | ERN1 | 4.43056410 |
4 | FGFR4 | 4.21756491 |
5 | TAOK3 | 3.43903531 |
6 | PKN2 | 3.06990716 |
7 | RIPK4 | 2.47530549 |
8 | TRIB3 | 2.37466924 |
9 | INSRR | 2.25704154 |
10 | TYK2 | 2.17123245 |
11 | ARAF | 2.04886826 |
12 | ERBB4 | 2.02965955 |
13 | FLT3 | 1.99237498 |
14 | MST1R | 1.86730761 |
15 | PIK3CG | 1.85260206 |
16 | PTK6 | 1.78810048 |
17 | MAPK11 | 1.75068531 |
18 | PRPF4B | 1.74093699 |
19 | PIM2 | 1.72621534 |
20 | FRK | 1.70100312 |
21 | FGR | 1.63206493 |
22 | GRK7 | 1.63174208 |
23 | GRK6 | 1.60917257 |
24 | MATK | 1.58047953 |
25 | MAP2K4 | 1.57479289 |
26 | MAP3K2 | 1.56744060 |
27 | MAP3K10 | 1.55698853 |
28 | TBK1 | 1.53133748 |
29 | IRAK4 | 1.50216136 |
30 | TAOK1 | 1.46069289 |
31 | MAP2K3 | 1.39979202 |
32 | JAK1 | 1.38261322 |
33 | FES | 1.38031562 |
34 | MAP4K1 | 1.37142216 |
35 | LATS1 | 1.34714770 |
36 | NEK9 | 1.31487556 |
37 | JAK2 | 1.30868891 |
38 | NME2 | 1.30391124 |
39 | CAMK1D | 1.27293284 |
40 | MAP3K14 | 1.25932716 |
41 | MAP3K7 | 1.21655957 |
42 | EPHB1 | 1.19408107 |
43 | PRKAA2 | 1.15911865 |
44 | KDR | 1.14290202 |
45 | TGFBR2 | 1.14195191 |
46 | MAP3K3 | 1.13331864 |
47 | BMPR2 | 1.12162511 |
48 | DDR2 | 1.07875999 |
49 | CSK | 1.06219548 |
50 | CSF1R | 1.05750165 |
51 | MOS | 1.02888161 |
52 | KSR2 | 1.02412883 |
53 | CDC42BPA | 1.01038631 |
54 | ABL2 | 1.00941719 |
55 | DAPK2 | 1.00871701 |
56 | RIPK1 | 1.00391112 |
57 | FGFR2 | 0.97544327 |
58 | CDK6 | 0.95410453 |
59 | MAPK4 | 0.93627685 |
60 | IKBKE | 0.91676087 |
61 | LCK | 0.87412782 |
62 | CDK12 | 0.84047193 |
63 | ADRBK2 | 0.83710828 |
64 | FGFR3 | 0.82804723 |
65 | IRAK3 | 0.82272706 |
66 | IRAK1 | 0.81918224 |
67 | MAP3K11 | 0.79725018 |
68 | DYRK1B | 0.76105955 |
69 | ZAP70 | 0.76063325 |
70 | MAPK12 | 0.75743139 |
71 | EPHA3 | 0.74957766 |
72 | KIT | 0.74379881 |
73 | PDK2 | 0.73776866 |
74 | TGFBR1 | 0.72173839 |
75 | ITK | 0.71841692 |
76 | ERBB2 | 0.71390329 |
77 | PDGFRA | 0.69457059 |
78 | CAMK1G | 0.68345609 |
79 | MAPK15 | 0.68104703 |
80 | PRKCZ | 0.67062458 |
81 | ICK | 0.66068040 |
82 | STK38L | 0.65887227 |
83 | ACVR1B | 0.65314627 |
84 | BLK | 0.64334245 |
85 | GSK3A | 0.62935897 |
86 | CDK4 | 0.61416551 |
87 | MARK3 | 0.60833811 |
88 | PTK2 | 0.60621791 |
89 | SGK3 | 0.60500345 |
90 | PRKACG | 0.59436352 |
91 | BTK | 0.56882191 |
92 | MAP3K13 | 0.56619620 |
93 | PRKAA1 | 0.56305672 |
94 | PRKCQ | 0.55513448 |
95 | STK10 | 0.55147803 |
96 | MAP2K6 | 0.55147639 |
97 | JAK3 | 0.54560991 |
98 | TEC | 0.54398379 |
99 | RET | 0.52622328 |
100 | STK24 | 0.51164909 |
101 | EEF2K | 0.50978936 |
102 | TRPM7 | 0.50610348 |
103 | MET | 0.49921387 |
104 | MAPK7 | 0.48650334 |
105 | PDPK1 | 0.48256478 |
106 | MARK2 | 0.47144753 |
107 | TNK2 | 0.46196392 |
108 | IGF1R | 0.45508844 |
109 | RPS6KL1 | 0.45309506 |
110 | RPS6KC1 | 0.45309506 |
111 | STK3 | 0.44122237 |
112 | FER | 0.44087455 |
113 | PDK1 | 0.43984107 |
114 | RPS6KA2 | 0.42425001 |
115 | PRKD2 | 0.42402243 |
116 | MAP3K5 | 0.42129628 |
117 | IRAK2 | 0.41888474 |
118 | PDGFRB | 0.41512989 |
119 | CHUK | 0.41403331 |
120 | TAOK2 | 0.41290817 |
121 | IKBKB | 0.41221562 |
122 | MTOR | 0.40016871 |
123 | LRRK2 | 0.39519349 |
124 | PAK4 | 0.38211602 |
125 | SMG1 | 0.38131734 |
126 | EGFR | 0.38076842 |
127 | BMX | 0.37600956 |
128 | LYN | 0.35000670 |
129 | SYK | 0.31192124 |
130 | TIE1 | 0.31077414 |
131 | ABL1 | 0.30611420 |
132 | SGK2 | 0.30158728 |
133 | TXK | 0.29432870 |
134 | PIM1 | 0.29361699 |
135 | HCK | 0.28924667 |
136 | MAP3K6 | 0.28516592 |
137 | CAMK2G | 0.26842516 |
138 | PIK3CA | 0.25474467 |
139 | NUAK1 | 0.25417161 |
140 | MAP3K1 | 0.24751286 |
141 | GRK1 | 0.24107243 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.46073437 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.63699394 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48473988 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.47685788 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.20970987 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.00230031 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.74319312 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70800394 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68827551 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56231363 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48507489 |
12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.44439916 |
13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.41584065 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.37760033 |
15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32567501 |
16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16986415 |
17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.14823647 |
18 | Asthma_Homo sapiens_hsa05310 | 2.06927235 |
19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05283295 |
20 | Peroxisome_Homo sapiens_hsa04146 | 2.05098927 |
21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.97407643 |
22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96799316 |
23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94617928 |
24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.93790707 |
25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93699449 |
26 | Allograft rejection_Homo sapiens_hsa05330 | 1.91985874 |
27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90599561 |
28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89691701 |
29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.87147348 |
30 | Tuberculosis_Homo sapiens_hsa05152 | 1.85748425 |
31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.84835865 |
32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.83546872 |
33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79481023 |
34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71862319 |
35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68505387 |
36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65894312 |
37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.64651699 |
38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.59816709 |
39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58581537 |
40 | Malaria_Homo sapiens_hsa05144 | 1.57644593 |
41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57548268 |
42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56411683 |
43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.54567357 |
44 | Bile secretion_Homo sapiens_hsa04976 | 1.54083414 |
45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.49441304 |
46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.47939071 |
47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47873012 |
48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.46277722 |
49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44598456 |
50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.44037844 |
51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43224954 |
52 | Legionellosis_Homo sapiens_hsa05134 | 1.38893827 |
53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38849696 |
54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32652879 |
55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32050176 |
56 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31723745 |
57 | Phagosome_Homo sapiens_hsa04145 | 1.29571575 |
58 | ABC transporters_Homo sapiens_hsa02010 | 1.29564151 |
59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27226234 |
60 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27159436 |
61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26931272 |
62 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26404971 |
63 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21595875 |
64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.18485822 |
65 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.18480547 |
66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17977531 |
67 | Influenza A_Homo sapiens_hsa05164 | 1.17008514 |
68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15994867 |
69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.14079434 |
70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12675431 |
71 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08958874 |
72 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06329177 |
73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00698278 |
74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00102650 |
75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00018455 |
76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98763353 |
77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.97142675 |
78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97100353 |
79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95822516 |
80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92630059 |
81 | Salmonella infection_Homo sapiens_hsa05132 | 0.91972780 |
82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89865462 |
83 | Lysine degradation_Homo sapiens_hsa00310 | 0.89014651 |
84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88784135 |
85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84986021 |
86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82831425 |
87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81576534 |
88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81476776 |
89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80891641 |
90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80281318 |
91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79610363 |
92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78569261 |
93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74892068 |
94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72258642 |
95 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71888269 |
96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71131575 |
97 | Measles_Homo sapiens_hsa05162 | 0.68898550 |
98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68098682 |
99 | Platelet activation_Homo sapiens_hsa04611 | 0.66720125 |
100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66584750 |
101 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66219429 |
102 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65291471 |
103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65227220 |
104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64874725 |
105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62680028 |
106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61295067 |
107 | Apoptosis_Homo sapiens_hsa04210 | 0.54473175 |
108 | Shigellosis_Homo sapiens_hsa05131 | 0.51657429 |
109 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51090565 |
110 | Bladder cancer_Homo sapiens_hsa05219 | 0.50806076 |
111 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.48493758 |
112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45641422 |
113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42037368 |
114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41976427 |
115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41192210 |
116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41094544 |
117 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40654531 |
118 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40438879 |
119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39846750 |
120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39281786 |
121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38634645 |
122 | Hepatitis B_Homo sapiens_hsa05161 | 0.38097960 |
123 | Insulin resistance_Homo sapiens_hsa04931 | 0.29967818 |
124 | Prion diseases_Homo sapiens_hsa05020 | 0.26593796 |
125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25877383 |
126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24493226 |
127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19892785 |
128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14541600 |
129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11246190 |
130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06532093 |
131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.04271485 |
132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04105428 |
133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02580368 |
134 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.02408258 |
135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2049238 |
136 | Mineral absorption_Homo sapiens_hsa04978 | -0.2011374 |
137 | Amoebiasis_Homo sapiens_hsa05146 | -0.1935332 |
138 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1764845 |
139 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1732643 |
140 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1616055 |
141 | Lysosome_Homo sapiens_hsa04142 | -0.1511877 |
142 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1431292 |
143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1394535 |
144 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1343440 |
145 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1310859 |
146 | Pertussis_Homo sapiens_hsa05133 | -0.1280877 |
147 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1265350 |
148 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1139888 |
149 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0917931 |
150 | Hepatitis C_Homo sapiens_hsa05160 | -0.0878851 |
151 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0743359 |
152 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0658120 |
153 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0414674 |